15-min delayed · Jul 28, 12:30 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for NTRB yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $2.96 current
Highest Target—
Average Target—
Lowest Target—
NTRB analyst recommendation trends
86420
Jul
Aug
Sep
Oct
Nov
Dec
Strong BuyBuyHoldSellStrong Sell
RATING
JUL
AUG
SEP
OCT
NOV
DEC
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
1
Hold
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Dec, 1 of 1 firms rate NTRB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NTRB EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 0 analysts
Next period, 0 analysts expect Nutriband Inc to earn — a share (range — – —), versus — a year earlier.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 0 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Nutriband Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NTRB.
#1
RL
Robert LeBoyer
Noble Financial
Buy
$15.00+407.6% to target
Coverage
—
+ Follow
#2
RL
Robert LeBoyer
Noble Capital Markets
Buy
$13.00+339.9% to target
Coverage
—
+ Follow
NTRB stock forecast FAQ
Who is the most accurate analyst covering NTRB?+
Among analysts who currently cover NTRB, Robert LeBoyer of Noble Financial has the strongest overall Quantellect track record. Their current call is Buy with a $15.00 target.
What is Nutriband Inc's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 0 analysts. Full-year EPS is projected at —, rising to — the following year.
How much revenue is Nutriband Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading NTRB lately?+
As of Dec, 1 of 1 firms rate NTRB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NTRB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
